Business
Re Portfolio Company
Re Portfolio Company.
About this update from Frontier Ip Group Plc
[{"type":"text","content":"\n \nRNS Number : 1788E Frontier IP Group plc 08 May 2013 \n \n\n \n \nAIM: FIPP\n \n \nFrontier IP Group Plc\n(\"Frontier IP\" or \"the Group\")\n \nPortfolio Company Aridhia Announces Strategic Partnership\n \nFrontier IP, which specialises in the commercialisation of university intellectual property, is pleased to note the following announcement in relation to one of its portfolio companies, Aridhia Informatics Limited (\"Aridhia\"). The full text of Aridhia's announcement is set out below.\n \n\"Strategic partnership signals new age of stratified medicine\n \nAridhia and Pivotal™ collaborating on revolutionary solutions for chronic disease management\n \nEdinburgh, UK - May 2nd, 2013 - Health and biomedical informatics company Aridhia today announced a strategic partnership with Pivotal, the company setting the new standard for Enterprise PaaS, to create a new technology platform capable of revolutionising the management of chronic health conditions such as cancer, diabetes and cardiovascular disease.\n \nDeveloping on the Pivotal One™ platform, the companies will work together to provide the international healthcare, life and biomedical science markets with applications and services that enable the rapid, sophisticated analysis of massive amounts of clinical, patient, imaging and genomic data and provide a comprehensive picture of factors affecting each patient's treatment and healthcare outcomes.\n \nThe collaboration will enable clinicians and researchers to gain fresh insights into correlations between patient, clinical and genomic data and usher in a new age of 'stratified medicine', offering improved, personalised treatments tailored to the genetics of individual patients.\n \nAs chronic diseases such as cancer, diabetes, respiratory and cardiovascular disease become increasingly prevalent worldwide, Aridhia's CEO and Chairman, Dr David Sibbald, believes healthcare organisations will rely more on real-time data analysis and disease management services to enhance service delivery, stratify patient risk and improve clinical outcomes.\n \n\"Chronic diseases are the leading cause of morbidity and mortality in the world. There is an urgent clinical and economic need to manage those conditions more effectively, which is why we are excited to have the oppo...